ArticleEClinicalMedicine2025

Duration, dose, and responsiveness to erythropoiesis-stimulating agents and risk of osteoporotic fracture among patients with chronic kidney disease in Hong Kong: a nested case-control study.

Shun-Cheong Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.